Table 1. Correlations between circMET with clinicopathologic features in 94 NSCLCs.
Variable | No. of patients | P value* | |
circMETlow | circMEThigh | ||
Age, year | |||
≥60 | 32 | 27 | 0.246 |
<60 | 20 | 15 | |
Gender | |||
Male | 29 | 22 | 0.367 |
Female | 23 | 20 | |
Smoking | |||
Yes | 38 | 25 | 0.523 |
No | 14 | 17 | |
Histologic type | |||
Squamous cell carcinoma | 26 | 24 | 0.218 |
Adenocarcinomas | 19 | 16 | |
Others | 7 | 2 | |
Tumor diameter(cm) | |||
≤3 | 29 | 11 | 0.006 |
>3 | 23 | 31 | |
TNM stage | |||
I-II | 34 | 14 | 0.249 |
III-IV | 18 | 28 | |
Differentiation | |||
Well/moderate | 34 | 12 | 0.015 |
Poor | 18 | 30 | |
Lymphatic metastasis | |||
Yes | 13 | 31 | 0.008 |
No | 39 | 11 | |
Distant metastasis | |||
Yes | 23 | 32 | 0.132 |
No | 29 | 10 |
A chi-square test was used for comparing groups between low and high circMET expression. *, p<0.05 was considered significant.